ISTANBUL JOURNAL OF PHARMACY, vol.51, no.2, pp.167-174, 2021 (ESCI)
Article / Article
ISTANBUL JOURNAL OF PHARMACY
Emerging Sources Citation Index (ESCI)
Metformin, genotoxicity, apoptosis, HepG2 cells, HeLa cells, ANTIDIABETIC DRUG METFORMIN, HEPATOCELLULAR-CARCINOMA, DNA-DAMAGE, CANCER, CELLS, PROSTATE, GROWTH, VIVO
Hacettepe University Affiliated:
Background and Aims: Recent studies have shown the anticancer properties of metformin, which is widely used in diabetes mellitus. The possible mechanisms of anticancer effects of metformin have not been fully elucidated. We aimed to investigate the cytotoxic, genotoxic, and apoptotic effects of metformin in HepG2 and HeLa cells.